AI Issuer Brief
Arphra AILoading cached brief…
Peers
- ALGNAlign Technology, Inc.$178.91$12.81B
- RDYDr. Reddy's Laboratories Limited$13.72$11.42B
- ELANElanco Animal Health Incorporated$22.51$11.24B
- ENSGThe Ensign Group, Inc.$183.72$10.73B
- EHCEncompass Health Corporation$107.48$10.69B
- UHSUniversal Health Services, Inc.$167.00$10.46B
- RVTYRevvity, Inc.$86.68$9.69B
- ICLRICON Public Limited Company$112.85$8.62B
Price change · trailing returns
Live · FMP| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.30% | -0.85% | +11.27% | +1.01% | -12.09% | -5.41% | +2.50% | -6.31% | -6.31% | -6.31% | -6.31% |
Aftermarket
Live · FMPLast trade
$74.95
116 sh
Bid
$74.07
1 sh
Ask
$77.50
13 sh
Spread
$3.430
Fair value
Football field →Weighted blend
$149.56
+99.55% vs spot
Recommendation
Strong Buy
14 of 14 methods
Method spread
8bull5bear
±5% threshold
Analyst PT consensus: $97.80 (+30.49%)
Total assets
$14.29B
Total debt
$5.04B
Cash & equiv
$878M
Operating CF
$369M
Free cash flow
-$10M
Buybacks
$0
Analyst view
DB · price_targets + analyst_gradesConsensus target
$97.80
+30.49% upside
Low
$92.00
Median
$100.00
High
$105.00
Recent actions
0 ↑0 ↓8 hold
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
- Dec 01, 2025
News
DB · news_items- Solventum Corporation (SOLV) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 13, 2026
- SOLV Energy Q1 Earnings Call Highlightsmarketbeat.com·May 12, 2026
- Solventum (SOLV) Recently Broke Out Above the 200-Day Moving Averagezacks.com·May 12, 2026
- SOLV Energy Reports First Quarter 2026 Resultsglobenewswire.com·May 12, 2026
- SOLV Energy Reports First Quarter 2026 Resultsglobenewswire.com·May 12, 2026
- Solventum to Participate in the 2026 BofA Securities Health Care Conferenceprnewswire.com·May 07, 2026
- Solventum Reports First Quarter 2026 Financial Resultsprnewswire.com·May 05, 2026
- Solventum to Post Q1 Earnings: Is a Beat Likely for the Stock?zacks.com·May 04, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 Dec 2025 | $2B | $63M | $0.37 |
| Q3 Sep 2025 | $2.1B | $1.27B | $7.22 |
| Q2 Jun 2025 | $2.16B | $90M | $0.51 |
| Q1 Mar 2025 | $2.07B | $137M | $0.78 |
| Q4 Dec 2024 | $2.08B | $31M | $0.18 |
| Q3 Sep 2024 | $2.08B | $122M | $0.70 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Wendell Amy McBride director | Buy | 1,475 | $100.34K | Mar 10, 2026 |
3M CO 10 percent owner | Sell | 9M | $646.36M | Aug 15, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $8.33B | $2.18B | $1.56B | $8.88 | +18.69% |
| FY 2024 | $8.25B | $1.04B | $479M | $2.76 | +5.80% |
| FY 2023 | $8.2B | $1.69B | $1.35B | $7.79 | +16.42% |
| FY 2022 | $8.13B | $1.69B | $1.34B | $7.79 | +16.52% |
| FY 2021 | $8.17B | $1.88B | $1.46B | $8.47 | +17.87% |